₹ 37.90
0.22 (0.58%)
BSE
S
Sandu Pharmaceuticals
₹ 37.90
BSE
SANDUPHQ Financials Summary (Consolidated)
Sandu Pharmaceuticals revenue decreased 23.37% quarter-on-quarter to ₹14 Cr in Mar 2025, while net profit decreased 50.00% quarter-on-quarter to ₹0 Cr. Compared to the same quarter last year, revenue is down 11.32% and net profit is down 50.00%. EPS for the quarter stood at ₹0.34, decreased from ₹0.57 in the previous quarter and down from ₹0.62 a year ago.
Sandu Pharmaceuticals Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of SANDUPHQ Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
SANDUPHQ Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






